Financial Snapshot

Revenue
$414.1M
TTM
Gross Margin
54.9%
TTM
Net Earnings
$52.20M
TTM
Current Assets
$298.4M
Q3 2023
Current Liabilities
$202.9M
Q3 2023
Current Ratio
147.02%
Q3 2023
Total Assets
$498.6M
Q3 2023
Total Liabilities
$459.2M
Q3 2023
Book Value
$39.39M
Q3 2023
Cash
P/E
3.415
Nov 29, 2024 EST
Free Cash Flow
$34.06M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2022 2021 2020 2019 2018
Revenue $409.9M $409.7M $331.5M $324.8M $324.8M
YoY Change 0.04% 23.61% 2.06% 0.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2022 2021 2020 2019 2018
Revenue $409.9M $409.7M $331.5M $324.8M $324.8M
Cost Of Revenue $1.786M $174.0M $140.2M $142.3M $142.3M
Gross Profit $239.6M $235.7M $191.3M $182.5M $182.5M
Gross Profit Margin 58.44% 57.53% 57.72% 56.19% 56.19%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2022 2021 2020 2019 2018
Selling, General & Admin $192.7M $159.9M $122.2M $145.1M $145.1M
YoY Change 20.47% 30.83% -15.74% 0.0%
% of Gross Profit 80.42% 67.85% 63.89% 79.49% 79.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $16.84M $15.11M $16.48M $16.47M $16.47M
YoY Change 11.47% -8.29% 0.07% 0.0%
% of Gross Profit 7.03% 6.41% 8.61% 9.02% 9.02%
Operating Expenses $199.5M $165.2M $128.3M $145.1M $145.1M
YoY Change 20.72% 28.84% -11.59% 0.0%
Operating Profit $40.09M $70.47M $63.05M $37.43M $37.43M
YoY Change -43.11% 11.76% 68.45% 0.0%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2022 2021 2020 2019 2018
Interest Expense $25.76M -$72.31M -$58.39M -$44.81M -$44.81M
YoY Change -135.63% 23.82% 30.31% 0.0%
% of Operating Profit 64.26% -102.61% -92.61% -119.71% -119.71%
Other Income/Expense, Net $23.49M -$85.32M -$3.811M -$2.599M -$2.599M
YoY Change -127.53% 2138.83% 46.63% 0.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2022 2021 2020 2019 2018
Pretax Income $52.71M -$87.16M $849.0K -$9.978M $0.00
YoY Change -160.48% -10365.96% -108.51%
Income Tax $10.17M $13.71M $11.30M $7.035M $7.035M
% Of Pretax Income 19.29% 1330.51%
Net Earnings $42.54M -$100.9M -$10.45M -$17.01M $0.00
YoY Change -142.18% 865.47% -38.58%
Net Earnings / Revenue 10.38% -24.62% -3.15% -5.24% 0.0%
Basic Earnings Per Share
Diluted Earnings Per Share $0.42 -$894.0K -$92.60K -$150.7K $0.00

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2022 2021 2020 2019 2018
Cash & Short-Term Investments $43.00M $72.11M $4.229M $30.00K $180.0K
YoY Change -40.37% 1605.18% 13996.67% -83.33% 0.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $4.344M $5.839M $360.0K $100.0K
YoY Change -25.6% 1521.94% 260.0%
Inventory $96.83M $79.43M $64.28M
Prepaid Expenses
Receivables $116.9M $118.6M $99.06M
Other Receivables $36.40M $22.08M $16.77M
Total Short-Term Assets $297.4M $298.1M $184.7M $30.00K $180.0K
YoY Change -0.21% 61.37% 615573.33% -83.33% 0.0%
Property, Plant & Equipment $113.0M $112.8M $113.5M
YoY Change 0.15% -0.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.715M $2.699M $3.221M $201.3M
YoY Change -36.46% -16.21% -98.4%
Other Assets $10.05M $11.60M $23.64M $210.0K $30.00K
YoY Change -13.33% -50.94% 11156.67% 600.0% 0.0%
Total Long-Term Assets $162.7M $164.1M $174.8M $210.0K $30.00K
YoY Change -0.81% -6.15% 83155.24% 600.0% 0.0%
Total Assets $460.2M $462.1M $359.5M $240.0K $210.0K
YoY Change
Accounts Payable $93.04M $86.72M $94.12M
YoY Change 7.29% -7.86%
Accrued Expenses $60.00K $10.00K
YoY Change 500.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $61.00K $7.115M $0.00 $170.0K $170.0K
YoY Change -99.14% -100.0% 0.0% 0.0%
Long-Term Debt Due $257.5M $74.65M $114.8M
YoY Change 245.0% -34.97%
Total Short-Term Liabilities $368.4M $188.0M $239.6M $230.0K $180.0K
YoY Change 95.98% -21.56% 104086.09% 27.78% 0.0%
Long-Term Debt $28.41M $178.7M $339.7M
YoY Change -84.1% -47.39%
Other Long-Term Liabilities $57.46M $127.7M $15.96M
YoY Change -55.01% 700.26%
Total Long-Term Liabilities $85.87M $306.4M $355.7M
YoY Change -71.98% -13.85%
Total Liabilities $461.1M $499.5M $615.0M $230.0K $180.0K
YoY Change -7.69% -18.77% 267288.26% 27.78% 0.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2022 2021 2020 2019 2018
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $178.26 Million

About Procaps Group, S.A.

Procaps Group SA is an international healthcare and pharmaceutical company. The firm develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. The company operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.

Industry: Pharmaceutical Preparations Peers: